Evidence map›Paper›PMID 39424955›Full record

ArticleEMBO reports2024

Glycogenesis and glyconeogenesis from glutamine, lactate and glycerol support human macrophage functions.

Najia Jeroundi, Charlotte Roy, Laetitia Basset, Pascale Pignon, Laurence Preisser, Simon Blanchard, Cinzia Bocca, Cyril Abadie, Julie Lalande, Naïg Gueguen and 8 more

Abstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Metabolic adaptation of glucose-deprived macrophages involves partial gluconeogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Najia Jeroundi *Univ Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.
Charlotte Roy *Univ Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.ORCID 0000-0002-8528-9995
Laetitia BassetUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.ORCID 0000-0001-7996-6470
Pascale PignonUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.
Laurence PreisserUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.
Simon BlanchardUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.ORCID 0000-0002-7953-0455
Cinzia BoccaUniv Angers, Inserm, CNRS, MitoVasc, SFR ICAT, F-49000, Angers, France.
Cyril AbadieUniv Angers, INRAe, IRHS, SFR QUASAV, F-49000, Angers, France.
Julie LalandeUniv Angers, INRAe, IRHS, SFR QUASAV, F-49000, Angers, France.
Naïg GueguenUniv Angers, Inserm, CNRS, MitoVasc, SFR ICAT, F-49000, Angers, France.
Guillaume MabilleauUniv Angers, Nantes Université, Inserm, Oniris, RMeS, SFR ICAT, F-49000, Angers, France.ORCID 0000-0003-1445-329X
Guy LenaersUniv Angers, Inserm, CNRS, MitoVasc, SFR ICAT, F-49000, Angers, France.
Aurélie MoreauInserm, Nantes Université, University Hospital of Nantes, Centre de Recherche Translationnelle en Transplantation et Immunologie, Nantes, France.
Marie-Christine CopinUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.
Guillaume TcherkezUniv Angers, INRAe, IRHS, SFR QUASAV, F-49000, Angers, France.
Yves DelnesteUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.
Dominique CouezUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France.
Pascale JeanninUniv Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, LabEx IGO, F-49000, Angers, France. pascale.jeannin@univ-angers.fr.ORCID 0000-0002-3666-3856

Funding

ANR | Labex Immuno-Oncology (ImmunoOnco) ANR-AA-LABX-0016-01
6 · The paper itself

Abstract

Macrophages fight infection and ensure tissue repair, often operating at nutrient-poor wound sites. We investigated the ability of human macrophages to metabolize glycogen. We observed that the cytokines GM-CSF and M-CSF plus IL-4 induced glycogenesis and the accumulation of glycogen by monocyte-derived macrophages. Glyconeogenesis occurs in cells cultured in the presence of the inflammatory cytokines GM-CSF and IFNγ (M1 cells), via phosphoenolpyruvate carboxykinase 2 (PCK2) and fructose-1,6-bisphosphatase 1 (FBP1). Enzyme inhibition with drugs or gene silencing techniques and

Indexed as

GlutamineGlycerolGlycogenLactic AcidMacrophagesCytokinesFructose-BisphosphataseGluconeogenesisGlycogenolysisGranulocyte-Macrophage Colony-Stimulating FactorHumansInterferon-gammaInterleukin-4Macrophage Colony-Stimulating FactorPentose Phosphate PathwayPhagocytosisCytokinesFructose-BisphosphataseGlutamineGlycerolGlycogenGranulocyte-Macrophage Colony-Stimulating FactorInterferon-gammaInterleukin-4Lactic AcidMacrophage Colony-Stimulating FactorPCK2 protein, humanPhosphoenolpyruvate Carboxykinase (ATP)Phosphoenolpyruvate Carboxykinase (GTP)Cytokine secretionGlycogenolysisGlyconeogenesisMacrophagesPhagocytosis

Identifiers

PMID39424955
PMCPMC11624281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.